Analysis of public prostate cancer datasets (12, 24, 25) revealed that the EHMT1 gene is altered in 1.6% of primary prostate cancer samples, and the alteration rate is increased to 7% in CRPC, with the majority being gene amplification (Fig. 1A). The gene discussed is EHMT1; the disease is prostate cancer.